Technische Universität Dresden
Clinical trials sponsored by Technische Universität Dresden, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- AI learns from thousands of ICU patients to improve ventilator care Results expected Sep 2026 (estimated)
- Can a simple blood test after pancreatic surgery save lives? Results expected Dec 2026 (estimated)
- AI co-pilot for robot surgery tested in rectal cancer patients Results expected Jan 2027 (estimated)
- Lung cancer immune markers under the microscope Results expected Mar 2027 (estimated)
- New drug cocktail aims to beat back a tough leukemia Results expected Apr 2027 (estimated)
-
Can targeted radiation slow prostate cancer that resists hormone therapy?
Disease control OngoingThis trial tests whether high-dose radiation aimed at a few cancer spots can slow the disease in men with prostate cancer that has stopped responding to hormone therapy. Half the participants receive radiation to their metastases, while the other half are watched without immediat…
Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Immunotherapy plus chemo shows promise for rare lung cancer
Disease control OngoingThis phase II trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy (platinum and etoposide) can help people with advanced large-cell neuroendocrine lung cancer live longer. About 67 participants who have not had prior systemic treatment wil…
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC